Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2019
Pharma News, 2019
SpePharm AG Wins Case Against Eisai Inc. in United States District Court for District of Delaware
AMSTERDAM, Sept.
Novo Nordisk to cut insulin prices in the U.S.
COPENHAGEN (Reuters) - Novo Nordisk will offer cheaper insulin to U.
FDA Grants AMG 510 Fast Track Designation for KRAS G12C+ NSCLC
The FDA has granted a fast track designation to AMG 510 for the treatment of patients with previously treated metastatic non–small cell lung cancer (NSCLC) harboring a KRAS G12C mutation.
Chicago biotech company 3D prints a mini human heart
The Chicago-based biotech company BIOLIFE4D announced today that it has successfully 3D-bioprinted a mini human heart.
Juul warned by FDA over marketing practices
(Reuters) - The U.
Malaria can be eradicated by 2050, say global experts
LONDON, Sept 8 (Reuters) - Malaria can be eradicated within a generation, global health experts have said.
FDA approves Ofev® as the first and only therapy to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD
RIDGEFIELD, Conn.
‘Unsafe’ levels of antibiotics found in rivers in 72 countries
Rivers worldwide are polluted with antibiotics that exceed environmental safety thresholds by up to 300 times, according to research unveiled at a conference Monday.
Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment
Takeda Pharmaceutical’s been looking for a buyer for Natpara to provide some debt relief, but it has just run into some complicating circumstances.
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech
It is now up to Vertex to make a success of the group’s technology, which involves using a device to allow the implantation of pancreatic islet cells in the hope of curing type 1 diabetes.
Trump Administration Announces $1.8 Billion in Funding to States to Continue Combating Opioid Crisis
Today, the U.
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report
In the 1980s, only 4% of new drugs approved by the FDA were cancer treatments.
13
14
15
16
17
18
19
20
21
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds